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Red Blood Cells Actively 
Contribute to Blood Coagulation 
and Thrombus Formation
Ingolf Bernhardt, Mauro C. Wesseling, Duc Bach Nguyen  
and Lars Kaestner
Abstract
The chapter describes the likely molecular mechanisms leading to the aggrega-
tion of human red blood cells (RBCs) under conditions of physiological coagulation 
when prostaglandin E2 (PGE2) or lysophosphatidic acid (LPA) is released from 
activated platelets and under pathophysiological conditions, in particular thrombi 
formation in sickle cell disease when patients are in a vaso-occlusive crisis. In 
both scenarios cation channels are activated. This leads to an increase of the free 
intracellular Ca2+ concentration resulting in an activation of the lipid scramblase, 
which in turn mediates a movement of phosphatidylserine (PS) from the inner to 
the outer membrane leaflet. In addition, the increased Ca2+ concentration leads to 
the activation of the Gardos channel. Experiments suggesting this mechanism have 
been performed with fluorescence microscopy, flow cytometry as well as single-cell 
force spectroscopy. The Ca2+-triggered RBC aggregation force has been identified to 
be close to 100 pN, a value large enough to play a significant role during thrombus 
formation or in pathological situations.
Keywords: red blood cells, intracellular Ca2+ concentration, phosphatidylserine, 
cation channels, lipid scramblase, thrombus formation
1. Introduction
It is well known that phospholipids are asymmetrically distributed in the cell 
membrane of most, if not all, living cells. Sphingomyelin (SM) and phosphati-
dylcholine (PC) are located predominantly in the outer leaflet of the membrane 
bilayer, while phosphatidylserine (PS) and phosphatidylethanolamine (PE) are 
located mostly in the inner leaflet [1] as depicted in Figure 1A. Figure 1B shows the 
possible movements of phospholipids from one leaflet of the membrane to the other 
one (for explanation see text below).
The distribution of the membrane phospholipids is realised by three main 
proteins: flippase [4], floppase and scramblase [2, 5, 6]. The flippase (also named 
aminophospholipid translocase (APLT)) transports relatively quickly (in some 
minutes) PS, and a bit slower PE, from the outer to the inner membrane leaflet. 
The floppase transports PC and SM in the opposite direction, i.e. from the inner 
to the outer membrane leaflet [2]. The flippase and floppase are ATP-dependent 
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and transport the phospholipids against their respective concentration gradients. 
The structure of the flippase has been published recently [7]. The scramblase is 
ATP-independent and activated by an increasing intracellular Ca2+ concentration in 
human red blood cells (RBCs) [8]. The scramblase has been identified recently as a 
member of the TMEM16 protein family, and the crystal structure was published [9]. 
The activity of the three proteins is shown in Figure 1B. PS exposure on the outer 
leaflet of the cell membrane has been described as a marker for apoptosis in nucle-
ated cells [5]. Although the programmed cell death of RBCs is still under discussion, 
these cells show some signs of apoptosis such as PS exposure, membrane blebbing 
and vesicle formation [10]. This process was denominated eryptosis by Lang et al. 
[11]. However, the use of this term is very controversial and finally not recom-
mended [12].
Figure 1. 
(A) The asymmetric distribution of phospholipids in the human red cell membrane. Abbreviations: 
SM, sphingomyelin; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine. 
(B) Transporter-controlled exchange of phospholipids between both lipid leaflets of the cell membrane. 
Unidirectional phospholipid transport by flippase is directed inwards, whereas floppase promotes outward 
directed transport. Both transporters are ATP-dependent and frequently move phospholipids against their 
respective concentration gradients. For example, aminophospholipid translocase ( flippase) rapidly shuttles 
PS and PE from outer to inner leaflet, while ABCC1 (floppase) moves both choline phospholipids and 
aminophospholipids more slowly towards the outer leaflet. The concerted action of both transporters is thought 
to create a dynamic asymmetric steady state, in which the outer monolayer is rich in choline phospholipids, 
whereas aminophospholipids predominantly occupy the inner leaflet. Bidirectional phospholipid transport 
is catalysed by a scramblase, the activation of which may occur following Ca2+ increase. Since scramblase 
activity moves all major phospholipid classes back and forth between the two leaflets, it promotes the collapse 
of membrane phospholipid asymmetry with appearance of PS at the cells’ outer surface. Panel (A) is modified 
from [2], and (B) is reproduced from [3].
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Based on findings showing a correlation between decreased haematocrit and 
longer bleeding times [13] and experiments of Andrews and Low [14], an active role 
of RBCs in thrombus formation has been proposed [14]. Kaestner et al. suggested 
a more detailed signalling cascade based on Ca2+ uptake via a non-selective cation 
channel that could be activated by prostaglandin E2 (PGE2) and/or lysophosphatidic 
acid (LPA) [15–17]. Recent considerations suggest more complicated signalling 
cascades to be involved [18, 19], including the participation of the mechanosensitive 
channel Piezo1 [20, 21].
Although it is known that LPA induces PS exposure on the outer membrane leaf-
let in RBCs, there are conflicting reports about the mechanism. While Chung et al. 
[22] claim that it is a totally Ca2+-independent process, we showed that Ca2+ alone 
is sufficient to induce PS exposure in human RBCs [23]. Woon et al. found that an 
increase of the intracellular Ca2+ level in RBCs results in the exposure of PS to the 
outer membrane leaflet due to the activation of the scramblase and inhibition of the 
flippase [24]. Protein kinase Cα (PKCα) has been also described to be involved in 
the PS exposure on RBCs [22, 25, 26]. A further discussion follows below.
An interesting model for lipid studies we consider below is sheep RBCs since it is 
known that these cells have a completely different phospholipid distribution in the 
membrane. Like in human RBCs, PS and PE are distributed in the inner membrane 
leaflet. In contrast, the sheep RBC (like all bovine RBC) membrane does not contain 
any PC, and the outer layer consists exclusively of SM [27, 28].
2. Stimulation of intracellular Ca2+ increase in human RBCs
PGE2 and LPA are local mediators released by platelets after their activation 
within the coagulation cascade. PGE2 can be even released by the RBCs themselves 
under conditions of mechanical stress [29]. We were able to show that the addition 
of both mediators to suspensions of human RBCs leads to an increase of the intra-
cellular free Ca2+ concentration in these cells. In the case of PGE2 (0.1 nM), 45% of 
the RBCs responded with increased Ca2+ content; in the case of LPA (5 μM), nearly 
all cells reacted [17, 30] but still showed a strong heterogeneity in the time course 
and the intensity of the response [31].
The identity of the Ca2+ entry was proposed to be channel-mediated; on the 
one hand, the CaV2.1-channel [32] and on the other hand the non-selective voltage 
dependent cation channel [17] were suggested. While the activation of CaV2.1 was 
linked to protein kinase C (PKC) activity [33], we could show that CaV2.1 and PKC 
belong to different signalling branches [18].
However, in a series of papers utilising fluorescence microscopy and flow cytom-
etry, we could link PKCα activity and Ca2+ entry [30, 34].
The above described effect is probably mediated by a specific pathway rather 
than a non-specific leak since the Ca2+ entry shows a clear dose-response relation-
ship towards the LPA concentration [35]. For a recent review about Ca2+ channels in 
human RBCs, see [36].
Another known port for Ca2+ entry that is likely to have some pathophysiologi-
cal relevance is the NMDA-receptor. Among the RBCs, NMDA-receptors were 
first identified in rat RBCs [37] but later also in human precursor cells as well as in 
circulating RBCs [38]. NMDA-receptors are cation channels permeable to Ca2+ and 
can be activated by homocysteine and homocysteic acid [39].
To extend on this, Figure 2 provides an overview of the current knowledge 
about Ca2+ entry and the major cellular consequences in different pathophysiologi-
cal conditions.
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3.  Increased intracellular Ca2+ content of human RBCs results in an 
activation of the scramblase
The PS exposure on the outer membrane leaflet of RBCs was studied for LPA-
treated cells using fluorescence microscopy. It has been shown that the number of 
annexin V-positive cells (i.e. cells showing PS exposure) after LPA treatment in the 
presence of Ca2+ is about 35% [30].
Experiments have also been carried out after treating the RBCs with LPA or the 
PKC-activator PMA but in the absence of extracellular Ca2+ (presence of 1 mM 
EGTA). In the case of LPA, we did not find significant differences between treat-
ment and control conditions (without activation) regarding PS exposure on human 
RBCs. Only in the case of PMA treatment, about 50% of RBCs showed PS exposure 
in the absence of Ca2+ (compared to about 80% in the presence of Ca2+). The data 
obtained for control conditions in the presence of Ca2+ were not significantly differ-
ent from the data of the control conditions in the absence of Ca2+ [30].
It is evident that for stimulation with the phorbol ester PMA, there is no 
 correlation between the number of cells showing an elevated Ca2+ content and 
the induced PS exposure, because it is known that PMA activates PKCα also in the 
absence of Ca2+.
Furthermore we like to state that the threshold for the forward scatter in the flow 
cytometry measurements was set in a way to make sure that only the events based 
on the size of intact cells were counted. This was of importance since we realised the 
formation of micro-vesicles after treatment with LPA as well as with PMA, which 
is in agreement with findings reported before [41, 42]. Calpain, a Ca2+-dependent 
Figure 2. 
Proposed mechanisms leading to increased intracellular Ca2+ levels in diseased RBCs. Alternative or cumulating 
Ca2+ entry pathways are highlighted with grey background: increased abundance of NMDA-receptors 
(NMDAR), e.g. in sickle cell disease; altered activity of Piezo1, e.g. in hereditary xerocytosis; increased 
activity of the Gardos channel, e.g. in Gardos Channelopathy; or unspecified Ca2+ transport mechanisms. 
Additionally, ineffective extrusion of Ca2+ due to disruption of ATP pools fuelling the plasma membrane Ca2+ 
ATPase (PMCA) can contribute. Several downstream processes follow Ca2+ overload in RBCs, e.g. activation 
of calmodulin by formation of the Ca2+-calmodulin complex (Ca-CaM) and activation of calpain, thereby 
loosening the cytoskeletal structure; activation of the scramblase (Scr) leading to exposure of phosphatidylserine 
on the outer leaflet of the membrane; activation of the Gardos channel followed by the efflux of K+, Cl− and 
H2O; and consecutive cell shrinkage. All these processes may lead to an increased RBC aggregation and/or 
accelerated RBC clearance, which is impaired when patients are splenectomised. This figure is modified from 
Hertz et al. [40].
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proteolytic enzyme, cleaves spectrin and actin, leading to cytoskeleton breakdown 
[43–45] and therefore could be involved in the vesiculation process.
The findings that Ca2+ content and PS exposure do not correlate in all cells were 
further supported by confocal fluorescence microscopy, where double-labelling 
experiments (for intracellular Ca2+ and PS in the outer membrane leaflet) have been 
carried out. The results of the LPA treatment showed that most of the cells have an 
elevated Ca2+ content and depict a PS exposure. However, some cells are display-
ing an increased Ca2+ level, but no PS exposure, whereas other cells externalise PS 
without having a higher Ca2+ content.
In the case of PMA treatment, PS exposure without high Ca2+ content is more 
pronounced, which is not surprising since PMA is an artificial compound, which 
activates conventional PKCs without the otherwise necessary presence of Ca2+.
The percentage of RBCs showing PS exposure after activation with LPA or PMA 
is significantly reduced after inhibition of the scramblase using the specific inhibi-
tor R5421 [34]. It is also significantly reduced after the inhibition of the PKCα using 
chelerythrine chloride or calphostin C. The inhibitory effect is more pronounced 
when the scramblase and the PKCα are inhibited simultaneously [34].
Based on our experiments, it seems reasonable to assume that at least three dif-
ferent mechanisms could be responsible for the PS exposure on RBCs:
• The first mechanism is related to the Ca2+-stimulated scramblase activation 
(and flippase inhibition) [4, 8, 10, 11, 47]. This effect involves the activation of 
the ω-agatoxin-TK-sensitive, CaV2.1-like (P/Q-type) Ca
2+ channel [33].
• The second mechanism involves the PKCα, which can be directly activated by 
PMA. It has been reported that PKCα is involved in the PS exposure in human 
RBCs [25, 26]. In addition, it has been shown that LPA activates in human 
RBCs both the PKCα (Ca2+-dependent) and the PKCζ (Ca2+-independent) 
[22]. Whether there is a direct activation of the scramblase in human RBCs by 
PKCα and/or PKCζ remains to be proofed. The more pronounced effect of PS 
exposure observed after treatment of RBCs with PMA as compared to LPA can 
be explained by assuming that PMA activates all available PKCα, whereas LPA 
stimulation triggers a signalling cascade [46] resulting only in partial activa-
tion of the PKCα pool.
• The third mechanism is the enhanced lipid flop caused by LPA [30]. This 
mechanism is the only one in sheep RBCs suggesting the absence of scramblase 
activity in these cells [30].
To consider a possible effect of cell volume alteration on PS exposure, experiments 
have been carried out where the physiological solution was replaced by a solution 
containing 150 mM KCl plus 2.5 mM NaCl instead of 145 mM NaCl plus 7.5 mM KCl. 
Under these conditions of a high extracellular KCl concentration, an opening of the 
Ca2+-dependent K+ channel (Gardos channel) does not result in a KCl loss and accom-
panying cell shrinkage. Based on this strategy, it has been found that a substantial part 
of the PS exposure in the presence of LPA is caused by the volume decrease.
It remains to be elucidated why, in the experiments reported above, some cells 
are displaying an increased Ca2+ level, but no PS exposure, whereas other cells 
externalise PS without having a higher Ca2+ content. In that context, we carried out 
single-labelling experiments (fluo-4 for intracellular Ca2+ and annexin V-FITC for 
exposed PS) and focussed on the shape of RBCs using also a fluorescence micro-
scope. The obtained results are presented in Figure 3.
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In Figure 3Aa one can see different cell shapes in the transmitted light image for 
LPA stimulation. However, the corresponding fluorescence image (Figure 3Ab) does 
not show differences of the increased Ca2+ content comparing RBCs with different 
shapes. The situation changes when analysing the PS exposure of the RBCs with differ-
ent shapes (Figure 3B). Again, RBCs with different shapes can be seen (Figure 3Ba), 
but in the case of PS exposure, the cell shape seems to play a significant role. Some echi-
nocytes can be seen in the transmitted light images (red circles in Figure 3Ba). Almost 
all of them lack PS exposure (corresponding fluorescence image in Figure 3Bb). Only 
one echinocyte showing PS exposure can be observed. The explanation of such an 
effect could be based on the bilayer couple hypothesis. If an echinocyte is formed, the 
outer membrane leaflet is already extended compared with the inner membrane leaflet. 
It means that any process of externalisation of a membrane lipid located mainly in the 
inner membrane leaflet is hindered. In addition we carried out experiments where we 
transferred the RBCs to different solutions as shown in  
Figure 3C and D. The RBC shapes, which predominantly occur in these solutions, are 
also indicated in Figure 3. Again, the PS exposure is lowest in solution where one can 
expect mostly echinocytes although the Ca2+ content is increased (red curves in  
Figure 3). The PS exposure of RBCs can be small also in solution where cells predomi-
nantly occur with the shape of discocytes or stomatocytes, however, in this case only in 
solutions where the increase of the intracellular Ca2+ content is prevented, e.g. physi-
ological solution of low pH (5.6, see violet curves in Figure 3).
Furthermore, we carried out double-labelling experiments (X-Rhod-1 for intracel-
lular Ca2+ and annexin V-FITC for exposed PS) and investigated the RBCs using a 
fluorescence microscope. The obtained results are presented in Figure 4. One RBC 
(indicated with white arrow in all panels of Figure 4) shows an increased intracellular 
Ca2+ content, but the cell suddenly disappeared from the transmitted light image 
Figure 3. 
Human RBC shapes after 2.5 μM LPA stimulation. Transmitted light (left) and fluorescence images (right) of 
RBCs. (A) Intracellular Ca2+ content detected using fluo-4, (B) PS exposure detecting using annexin V-FITC.  
(C, D) Flow cytometric analysis of responding cells after LPA stimulation in different solutions correlate with 
predominant cell shapes. Predominantly discocytes, physiological solution (black); predominantly echinocytes, 
low ionic strength solution + DIDS (red) and physiological solution + DIDS (orange); predominantly 
stomatocytes or discocytes, low ionic strength solution (blue); physiological solution at pH 5.6 (violet).
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(Figure 4Ab). However, PS exposure of this cell still can be seen (Figure 4Bb). It can 
be assumed that this RBC lysed, i.e. we see the remaining membrane structure  
(a ghost) and the Ca2+-sensitive fluorescent dye diffused out of the cell.
A different behaviour of RBCs depending on the age of the cell has been con-
troversially discussed. Therefore, we performed additional short-time incubation 
experiments, comparable to the experiments carried out by Nguyen et al. [30], with 
RBCs separated in five fractions with different cell age according to the method of 
Lutz et al. [47]. The intracellular Ca2+ content and PS exposure at the outer mem-
brane leaflet of human RBCs with different age have been investigated using, e.g. 
LPA stimulation. Here we present a reanalysis of these already published data [48].  
Interestingly, the percentage of RBCs showing increased Ca2+ content and PS 
Figure 4. 
RBCs were stimulated with lysophosphatidic acid, and panels (A) depict images 1 min after the start of the 
stimulation and panels (B) 1.5 min after the beginning of the stimulation. Panel (A) shows wide-field images 
and panel (B) confocal sections of the fluorescent biomarkers X-Rhod-1 (a Ca2+ indicator) and FITC-labelled 
annexin V (for PS detection). Panel (C) is an overlay of panels (A) and (B). The white arrow points to a cell 
that lysed after capturing images (a), i.e. in images (b) it’s a ghost.
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exposure depict a linear behaviour in dependence of cell age with a very good 
regression, R2 of 0.94 and 0.92, respectively, as outlined in Figure 5A. However, the 
slope of this linear regression failed to be significantly different from zero.
After stimulation of the RBCs with LPA, the situation is even more complex. 
Figure 5B depicts the situation after 15 min of LPA stimulation. While the Ca2+ 
concentration seems to relate inversely proportional to RBC age, PS-positive cells 
show a rather quadratic dependence on cell age. This is in contradiction to earlier 
investigations we performed on mouse RBCs [31]. Although we cannot completely 
resolve the situation part of the explanation might be caused in the detection 
technique: While microscopy is a rather gentle approach, in flow cytometry the 
cells under investigation experience high pressure and significant shear forces [60]. 
Therefore a significant number of high Ca2+ cells that are more fragile may lyse in 
the flow cytometer and hence are excluded from the detection.
Furthermore it is worthwhile to mention that under in vivo conditions, cells 
with a permanent high Ca2+ content and/or PS exposure are removed from the 
circulation, mostly in the spleen, while after long in vitro incubation time (48 h), 
old RBCs responded with higher increase of intracellular Ca2+ content as well as 
higher PS exposure compared to young RBCs [48, 49].
The intracellular Ca2+ content and the PS exposure at the outer membrane leaflet 
have been investigated for human RBCs also in physiological solutions prepared 
with oxygen-enriched water (in comparison to normal physiological solution). This 
was a study for a company (futomat®) producing equipment for the production of 
oxygen-enriched water for drinking. It has been found that Ca2+ content and the 
PS exposure are not changed significantly in oxygen-enriched water. However, one 
interesting effect was found when the RBCs were treated with LPA. Under such 
conditions the PS exposure was significantly reduced in futomat® water compared 
to normal physiological solution. It remains open and requires clinical studies to 
see whether there is a relevant effect in human beings, meaning a positive effect 
preventing thrombus formation.
4. Active role of RBCs in blood coagulation
When the endothelium of blood vessels is damaged, platelets become activated 
and transport PS to their external membrane surface [50]. After activation, the 
exposed PS provides a catalytic surface for the formation of active enzyme-substrate 
Figure 5. 
Reanalysis of data initially presented in [48]. In the original publication, only two fractions were compared 
with each other, while here we followed the approach to plot (and analyse) the measured effect in dependence 
of the cell age. (A) presents the situation under control conditions (without stimulation) and (B) the after 
15 min stimulation with LPA (p < 0.5 is marked with *).
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complexes of the coagulation cascade, especially for the tenase and prothrombinase 
complexes [51]. Under these circumstances exposed PS provides a procoagulant 
surface and is, in general, needed as a response to injury. Therefore, the mechanism 
of PS exposure has to occur with a relative high transport rate of the lipids. Platelets 
treated with a Ca2+ ionophore show a phospholipid scrambling rate of 78 × 103 per 
second [51]. Human RBCs also show the mechanism of PS exposure after increased 
intracellular Ca2+ content (see above) and are able to adhere to endothelial cells 
under pathophysiological conditions [22, 52–54]. In addition, exposed PS is sought 
to serve as a signalling component for macrophages to eliminate old or damaged 
RBCs from the circulation [55–58]. Since PS-exposing RBCs can adhere to the vascu-
lar wall, which may lead to disturbance of the microcirculation [59], the elimination 
of these cells is a very important mechanism. However, compared to platelets, RBCs 
have a lower phospholipid scrambling rate (0.45 × 103 per second) [51].
Figure 6. 
(A) shows a sketch of the working principle of single-cell force spectroscopy (SCFS). A cell is bound to a 
cantilever and is brought into contact with another cell at the surface. During the approach and withdrawal 
of the cell, the deflection is monitored and gives direct information about the adhesion force between the cells. 
(B) shows a sketch of the working principle of the optical tweezer measurements. Two RBCs are trapped in 
the foci of two laser beams and are brought into contact. By measuring the deflection of the cells out of the 
centre of the laser foci, one can determine the adhesion force between the cells. (C) shows a force vs. distance 
curve derived from the SSFS measurements. A weak interaction of approximately 20 pN can be observed that 
is mainly due to an artefact of the measurement (see original paper). This 20 pN is the lower limit that one 
can measure using this type of cell with this technique. (D) shows a force calibration of one RBC in an optical 
trap. It can be observed that with the given laser power, the trap is only linear up to forces of 15 pN, i.e. this is 
the upper limit that can be measured with this technique on these types of cells. This figure is reproduced with 
kind permission from Elsevier. (A) is a reprint from [23], panels (B) and (D) are reprints from [35] and 
panel (C) is a reprint from [60].
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Even more important was the demonstration that human RBCs play an active 
role in clot formation [23]. This is lacking in medical textbooks, where one can 
find statements claiming that RBCs only become part of clots because they are so 
abundant in the circulation. First demonstration of increased interacting forces 
between two RBCs when the intracellular free Ca2+ concentration is increased was 
performed using non-invasive holographic optical tweezers [23]. In addition, using 
single-cell force spectroscopy, it has been shown that the upper force limit for Ca2+-
triggered adhesion of the RBCs was approximately 100 pN, a value large enough to 
be of significance during clot formation or in pathological situations [23]. Figure 6 
summarises the in vitro force measurements performed.
5. Active participation of RBCs in thrombotic events
There are numerous indications for the active participation of RBCs in the 
induction of thrombotic events. The first example we like to mention is the 
occurrence of thrombotic complications in anaemic patients that experienced 
a splenectomy. Numerous hereditary anaemic disorders such as spherocytosis, 
stomatocytosis or elliptocytosis are associated with distorted RBCs, which are 
preferentially removed in the spleen. Therefore, splenectomy is believed to 
improve the anaemic symptoms because cells cannot be removed in the spleen. In 
principle, this concept works out but with the severe side effect that some patients 
suffer from thrombotic events. Since the ‘maintenance’ of the RBCs in the spleen 
is missing, it is likely that the RBCs are the major cause for the thrombotic events. 
In patients diagnosed with hereditary xerocytosis, mostly related to mutations in 
the Piezo1 channel, thrombotic complications were regularly reported after these 
patients underwent splenectomy [61], whereas patients diagnosed for ‘Gardos 
Channelopathy’, even after splenectomy, thrombotic events were not observed [62].
An even more prominent example is sickle cell disease associated with vaso-
occlusive pain crisis as the major and most severe symptom of the patients. Since the 
mutation associated with sickle cell disease is in the haemoglobin, it seems obvious 
that also the symptoms of the disease are associated with RBCs. The common belief is 
that vaso-occlusive pain crises in sickle cell disease patients are caused by the crystal-
lisation of the mutated haemoglobin under deoxygenation conditions. While the sickle 
formation under deoxygenation at stasis is undoubted, it’s not clear if the same shape 
change happens in vivo. However, although it is clear that deoxygenated RBCs of sickle 
cell disease patients have an impaired deformability, the link to the vaso-occlusive 
crises must be a bit more complicated because deoxygenation happens continuously as 
deoxygenated RBCs are continuously passing the circulation and vaso-occlusive pain 
crises happen only sporadically and are so far unpredictable. A possible explanation 
is the activity of the NMDA-receptors (see above) that are activated by homocysteine 
and homocysteic acid, which are markers for inflammation in the blood plasma [63].
Such the above described mechanisms triggered by intracellular Ca2+ increase 
are likely to happen also during vaso-occlusive crises in sickle cell disease patients. 
A first clinical pilot study on sickle cell disease patients using memantine, a drug 
blocking the NMDA-receptor (and approved to treat Alzheimer disease), showed 
very promising results both in the support of the mechanism we sketch and in the 
patients showing a lower number and less severe vaso-occlusive pain crises [64, 65].
Furthermore, it is well known that in RBCs of sickle cell disease patients, the 
Gardos channel activity is increased [66], which is an indicator for an increased 
Ca2+ since the Gardos channel is a Ca2+-activated K+ channel. However, a clinical 
trial testing senicapoc, a Gardos channel inhibitor, failed because vaso-occlusive 
crises were not improved [66]. Since senicapoc addresses the Gardos channel and 
11
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Red Blood Cells Actively Contribute to Blood Coagulation and Thrombus Formation
DOI: http://dx.doi.org/10.5772/intechopen.86152
not the upstream increase in Ca2+ that causes all the effects described above, the 
failure of senicapoc is explainable.
Additionally, we like to mention and discuss another aspect: The process we 
describe, in particular the Ca2+-triggered aggregation to initiate thrombus forma-
tion, takes some time [23], and an argument is that the time required is too long 
that aggregation happens between the fast-moving RBCs in the circulation. In this 
context, we like to mention the hydrodynamic clustering [67], which is perfectly 
reversible but provides the cellular interaction time since the lifetime of the hydro-
dynamic clusters can be in the range of several seconds.
6. Conclusions and outlook
It seems obvious that RBC participation in blood coagulation and thrombus for-
mation is more than an accidental trapping in the process. In this chapter we sum-
marised indications, evidences and proofs for active participation of RBCs in blood 
clotting and thrombus formation. However, this concept so far did not make it into 
haematological text books and standard medical education. With this book chapter, 
we like to make a little contribution to better explain and propagate this concept. 
Although we face severe experimental and clinical evidence for the active participa-
tion of RBCs in blood coagulation and thrombus formation, there is a demand for 
further research on the regulation and manipulation of this aspect in the coagula-
tion sometimes also referred to as RBC hypercoagulation. We are looking forward to 
the next years of investigations in coagulation and thrombosis research.
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